Unknown

Dataset Information

0

KEAP1 Editing Using CRISPR/Cas9 for Therapeutic NRF2 Activation in Primary Human T Lymphocytes.


ABSTRACT: Oxidant stress modifies T lymphocyte activation and function. Previous work demonstrated that murine T cell-specific kelch like-ECH-associated protein 1 (Keap1) deletion enhances antioxidant capacity and protects from experimental acute kidney injury. In this study, we used CRISPR technology to develop clinically translatable human T cell-specific KEAP1 deletion. Delivery of KEAP1 exon 2 specific Cas9:guide RNA in Jurkat T cells led to significant (?70%) editing and upregulation of NRF2-regulated antioxidant genes NADPH dehydrogenase quinone 1 (NQO1) (up to 11-fold), heme oxygenase 1 (HO1) (up to 11-fold), and GCLM (up to 2-fold). In primary human T cells, delivery of KEAP1 exon 2 target site 2-specific ATTO 550-labeled Cas9:guide RNA edited KEAP1 in ?40% cells and significantly (p ? 0.04) increased NQO1 (16-fold), HO1 (9-fold), and GCLM (2-fold) expression. To further enrich KEAP1-edited cells, ATTO 550-positive cells were sorted 24 h after electroporation. Assessment of ATTO 550-positive cells showed KEAP1 editing in ?55% cells. There was no detectable off-target cleavage in the top three predicted genes in the ATTO 550-positive cells. Gene expression analysis found significantly (p ? 0.01) higher expression of NQO1 mRNA in ATTO 550-positive cells compared with control cells. Flow cytometric assessment showed increased (p ? 0.01) frequency of CD4-, CD25-, and CD69-expressing KEAP1 edited cells whereas frequency of CD8- (p ? 0.01) and IL-17- (p ? 0.05) expressing cells was reduced compared with control cells. Similar experimental conditions resulted in significant KEAP1 editing, increased antioxidant gene expression, and frequency of CD69 and IL-10 positive cells in highly enriched KEAP1-edited regulatory T cells. KEAP1-edited T cells could potentially be used for treating multiple human diseases.

SUBMITTER: Noel S 

PROVIDER: S-EPMC5821541 | biostudies-literature | 2018 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

<i>KEAP1</i> Editing Using CRISPR/Cas9 for Therapeutic NRF2 Activation in Primary Human T Lymphocytes.

Noel Sanjeev S   Lee Sul A SA   Sadasivam Mohanraj M   Hamad Abdel R A ARA   Rabb Hamid H  

Journal of immunology (Baltimore, Md. : 1950) 20180119 5


Oxidant stress modifies T lymphocyte activation and function. Previous work demonstrated that murine T cell-specific kelch like-ECH-associated protein 1 (<i>Keap1</i>) deletion enhances antioxidant capacity and protects from experimental acute kidney injury. In this study, we used CRISPR technology to develop clinically translatable human T cell-specific <i>KEAP1</i> deletion. Delivery of <i>KEAP1</i> exon 2 specific Cas9:guide RNA in Jurkat T cells led to significant (∼70%) editing and upregula  ...[more]

Similar Datasets

| S-EPMC6225032 | biostudies-literature
| S-EPMC8038529 | biostudies-literature
| S-EPMC4978904 | biostudies-other
| S-EPMC8811649 | biostudies-literature
| S-EPMC6340735 | biostudies-literature
| S-EPMC5069954 | biostudies-literature
| S-EPMC9795164 | biostudies-literature
| S-EPMC7851445 | biostudies-literature
| S-EPMC8456651 | biostudies-literature
| S-EPMC7349023 | biostudies-literature